PDCD1 and infectious disease: Further, ICIs targeting PD-1 and LAG-3 have been explored in infectious disease contexts such as HIV, where ICI application has been shown to reactivate the viral reservoir25,52 as well as enhance HIV-specific conventional T cells responses26,53–55, leading to a potential role in a functional cure approach.